GLRA
Gerald L. Ray & Associates’s iShares Biotechnology ETF IBB Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q3 | $4.86M | Sell |
14,577
-168
| -1% | -$56K | 0.61% | 42 |
|
2017
Q2 | $4.57M | Buy |
14,745
+384
| +3% | +$119K | 0.59% | 42 |
|
2017
Q1 | $4.21M | Buy |
14,361
+1,449
| +11% | +$425K | 0.58% | 45 |
|
2016
Q4 | $3.43M | Buy |
12,912
+630
| +5% | +$167K | 0.5% | 51 |
|
2016
Q3 | $3.56M | Buy |
12,282
+768
| +7% | +$222K | 0.53% | 49 |
|
2016
Q2 | $2.96M | Buy |
11,514
+962
| +9% | +$248K | 0.47% | 57 |
|
2016
Q1 | $2.75M | Buy |
10,552
+2,477
| +31% | +$646K | 0.45% | 55 |
|
2015
Q4 | $2.73M | Sell |
8,075
-20
| -0.2% | -$6.77K | 0.43% | 56 |
|
2015
Q3 | $2.46M | Sell |
8,095
-225
| -3% | -$68.3K | 0.41% | 63 |
|
2015
Q2 | $3.07M | Sell |
8,320
-30
| -0.4% | -$11.1K | 0.47% | 56 |
|
2015
Q1 | $2.87M | Sell |
8,350
-15
| -0.2% | -$5.15K | 0.43% | 58 |
|
2014
Q4 | $2.54M | Sell |
8,365
-17
| -0.2% | -$5.16K | 0.39% | 63 |
|
2014
Q3 | $2.29M | Buy |
8,382
+25
| +0.3% | +$6.84K | 0.37% | 72 |
|
2014
Q2 | $2.15M | Buy |
8,357
+2,077
| +33% | +$534K | 0.37% | 74 |
|
2014
Q1 | $1.49M | Buy |
6,280
+345
| +6% | +$81.6K | 0.27% | 90 |
|
2013
Q4 | $1.35M | Sell |
5,935
-110
| -2% | -$25K | 0.25% | 89 |
|
2013
Q3 | $1.27M | Sell |
6,045
-50
| -0.8% | -$10.5K | 0.26% | 90 |
|
2013
Q2 | $1.06M | Buy |
+6,095
| New | +$1.06M | 0.24% | 97 |
|